Status | Study |
Not yet recruiting |
Study Name: Additive Benefit of the Urine LAM Test to Current TB Diagnostics in HIV Positive Adults in Panama City, Panama Condition: Tuberculosis HIV Histoplasmosis Date: 2016-07-21 Interventions: Other: Urine LAM Ag test TB diagnostic assay |
Completed |
Study Name: A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers Condition: Superficial Mycoses Dermatomycoses Candidiasis Date: 2015-07-07 Interventions: Drug: Lozanoc 50mg Lozanoc 50m |
Active, not recruiting |
Study Name: Prevalence of Histoplasmosis in HIV + Patients With a Rapid Diagnostic Test in West Indies Condition: HIV Date: 2013-06-20 |
Recruiting |
Study Name: Treatment for Presumed Ocular Histoplasmosis Condition: Ocular Histoplasmosis Date: 2013-02-11 Interventions: Drug: aflibercept |
Active, not recruiting |
Study Name: Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome Condition: Choroidal Neovascularization Presumed Ocular Histoplasmosis Date: 2012-04-02 Interventions: Drug: EYLEA (Aflibercept) intravitreal injection Intravitreal Injection once every 8 weeks with 3 initia |
Withdrawn |
Study Name: Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD Condition: Choroidal Neovascularization Myopia Punctate Inner Choroid Date: 2010-10-29 Interventions: Drug: Bevacizumab (Avastin; Genentech, Inc.) |
Recruiting |
Study Name: Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome Condition: Ocular Histoplasmosis Syndrome Date: 2009-08-07 Interventions: Drug: ranibizumab 3 monthly in |
Completed |
Study Name: A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection Condition: Mycoses Candidiasis Aspergillosis Date: 2008-10-23 Interventions: Drug: ITCZ Oral Solution ITCZ |
Completed |
Study Name: A Multi-center Study of Spherule-Derived Coccidioidin Condition: Coccidioidomycosis Date: 2008-06-02 Interventions: Biological: Spherule-derived coccidioidin 1.27 ug of sterile, injectable product (spherule-derived cocci |
Completed |
Study Name: Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization Condition: Neovascularization Tuberculosis Multifocal Serpiginous Cho Date: 2008-03-25 |